Ninjurin-1 mediates hepatic ischemia-reperfusion injury

Authors:
Publisher website
Google Scholar
Abstract
Lytic cell death pathways drive hepatic ischemia-reperfusion injury (IRI). The transmembrane protein ninjurin-1 (NINJ1) aggregates in the plasma membrane to permeabilize the cell during multiple cell death pathways implicated in hepatic IRI. We hypothesized that NINJ1 mediates liver IRI and that its inhibition would mitigate injury. We found that NINJ1 is highly expressed in human liver tissue and that its up-regulation and activation correlate with early allograft dysfunction in liver transplant patients. Using a segmental hepatic IRI model in mice and rats, Ninj1 genetic deletion or pharmacologic inhibition diminished acute injury. Mice with hepatocyte- or macrophage-specific Ninj1 knockout had reduced hepatocellular injury following IRI, suggesting that NINJ1 within both populations contributes to the resulting liver injury. Mechanistically, we found that hepatocytes and Kupffer cells are susceptible to hypoxia-induced NINJ1-mediated plasma membrane rupture, which can be pharmacologically prevented. We therefore position NINJ1 as a potential new therapeutic target to limit hepatic IRI, with important implications for liver transplantation.
Funding Information
  • Canadian Institutes of Health Research
  • Canadian Institutes of Health Research
  • Canadian Institutes of Health Research (CAN-TAP Talent Postdoctoral Fellowship Award)
  • Ajmera Transplant Centre (Translational Research Seed Grant)
  • Hospital for Sick Children Foundation (Team Izzy Innovator Award)
  • Department of Anesthesiology and Pain Medicine, University of Toronto (Merit Award)
  • American Transplant Congress Fellowship
  • American Society of Transplant Surgeons Faculty (Perfusion Grant)

This publication has 69 references indexed in Scilit: